Mild acne may be initially treated with this first line agent:

Acne vulgaris is a common inflammatory skin condition caused by follicular plugging, excess sebum production, Cutibacterium acnes proliferation, and inflammation. Treatment is based on severity, with mild acne typically managed using topical therapies that reduce bacterial load and prevent comedone formation. First-line management prioritizes safe, effective, and low-risk treatments before progressing to combination or systemic therapies. Over-the-counter options are commonly used as initial therapy for mild cases. Rationale: A. Topical retinoids are effective for acne because they normalize follicular keratinization and prevent comedone formation. However, they are often used as part of a broader treatment plan and may cause skin irritation, dryness, and photosensitivity. While useful, they are not always the simplest first-line monotherapy option for very mild acne compared to benzoyl peroxide alone. B. Benzoyl peroxide and clindamycin (Benzaclin) is typically reserved for moderate acne or cases where bacterial inflammation is more pronounced. While effective, combination therapy with an antibiotic is not necessary for mild acne and may contribute to antibiotic resistance if overused. Therefore, it is not the preferred initial monotherapy for mild disease. C. Minocycline (Minocin) is a systemic antibiotic used for moderate to severe inflammatory acne. It is not indicated for mild acne due to risks such as antibiotic resistance, gastrointestinal side effects, photosensitivity, and potential long-term adverse effects. Oral therapy is reserved for more extensive or refractory cases. D. Over-the-counter benzoyl peroxide is the first-line treatment for mild acne because it effectively reduces Cutibacterium acnes and decreases inflammation without contributing to antibiotic resistance. It is safe, widely available, and well tolerated for initial management. This makes it the most appropriate starting therapy for mild acne presentations.